A Long-term Follow-up of the HIV-NAT Cohort
ConditionHIV Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe HIV Netherlands Australia Thailand Research Collaboration
About this trial
With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients treated with combination antiretroviral therapy will provide further insights into the long-term safety and durability of various antiretroviral therapeutic approached, the efficacy of HIV viral load and CD4 cell counts as predictors of disease progression and mortality, and the importance of adherence.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
HIV infected patients( children and adults) previously participated HIV-NAT studies
HIV infected patients( children and adults) currently participate in HIV-NAT trials
Able to provide written consent
Disqualifiers
Unable to provide written consent
Trial population
All HIV infected adult patients from HIV-NAT.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
HIV infection
This cohort will collect various information such as but not limited to: comorbidity, mortality, cardiovascular, neurological clinical data, treatment history, serious adverse events, PBMCs, clinical outcomes, virological outcomes, resistance, failure, aging, other opportunistic infections, etc
Time frame
30 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov